/NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR
DISSEMINATION IN THE UNITED
STATES/
TORONTO, Aug. 22,
2022 /CNW/ - Chemtrade Logistics Income Fund (TSX:
CHE.UN) ("Chemtrade" or the "Fund") announced today
that it has completed its previously-announced public offering of
trust units ("Trust Units") at a price of $8.65 per Trust Unit. The underwriters elected to
exercise the over-allotment option in full, resulting in a total of
10,005,000 Trust Units being issued today for gross proceeds of
approximately $86.5 million (the
"Offering"). The Trust Units were sold to a syndicate of
underwriters led by BMO Capital Markets and RBC Capital Markets,
and which included CIBC Capital Markets, National Bank Financial
Inc., Scotiabank, TD Securities Inc. and Desjardins Securities Inc.
(collectively, the "Underwriters"), on a bought deal
basis.
Chemtrade intends to use the net proceeds from the Offering to
partially finance Chemtrade's previously announced ultrapure
sulphuric acid growth projects to expand capacity at its existing
Ohio plant and to build a new
plant in Arizona. Pending any such
use, the net proceeds from the Offering will temporarily be used to
reduce indebtedness under the Fund's existing credit agreement.
Chemtrade believes that additional capacity for ultrapure sulphuric
acid is required to support the fast-growing semiconductor industry
in the United States.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy securities, nor shall there be any
offer, solicitation or sale of the securities, in any jurisdiction
in which such offer, solicitation or sale would be unlawful.
About Chemtrade
Chemtrade operates a diversified business providing industrial
chemicals and services to customers in North America and around the world. Chemtrade
is one of North America's largest
suppliers of sulphuric acid, spent acid processing services,
inorganic coagulants for water treatment, sodium chlorate, sodium
nitrite, sodium hydrosulphite and phosphorus pentasulphide.
Chemtrade is also the largest supplier of high purity sulphuric
acid for the semiconductor industry in North America. Chemtrade is a leading regional
supplier of sulphur, chlor-alkali products, liquid sulphur dioxide,
and zinc oxide. Additionally, Chemtrade provides industrial
services such as processing by-products and waste streams.
Caution Regarding Forward-Looking
Statements
Certain statements contained in this news release constitute
forward-looking information within the meaning of certain
securities laws, including the Securities Act (Ontario). Forward-looking information can be
generally identified by the use of words such as "anticipate",
"continue", "estimate", "expect", "expected", "intend", "may",
"will", "project", "plan", "should", "believe" and similar
expressions. Specifically, forward-looking information in this news
release include statements regarding the Fund's ultrapure sulphuric
acid plants and the Fund's expected use of the net proceeds of the
Offering, including the Fund's intention to finance its ultrapure
sulphuric acid growth projects in Ohio and Arizona. Forward-looking statements in this
news release describe the expectations of the Fund and its
subsidiaries as of the date hereof.
These statements are based on assumptions and involve known and
unknown risks, uncertainties and other factors that may cause
actual results or events to differ materially from those
anticipated in such forward-looking statements for a variety of
reasons. Although the Fund believes the expectations reflected in
these forward-looking statements and the assumptions upon which
they are based are reasonable, no assurance can be given that
actual results will be consistent with such forward-looking
statements, and they should not be unduly relied upon. With respect
to the forward-looking statements contained in this news release,
the Fund has made assumptions regarding: there being no significant
disruptions affecting the operations of Chemtrade and its
subsidiaries, whether due to labour disruptions, supply
disruptions, power disruptions, transportation disruptions, damage
to equipment or otherwise; the ability of Chemtrade to sell
products at prices consistent with current levels or in line with
Chemtrade's expectations; the ability of Chemtrade to obtain
products, raw materials, equipment, transportation, services and
supplies in a timely manner to carry out its activities and at
prices consistent with current levels or in line with Chemtrade's
expectations; the timely receipt of required regulatory approvals;
the cost of regulatory and environmental compliance being
consistent with current levels or in line with Chemtrade's
expectations; the ability of Chemtrade to successfully access tax
losses and tax attributes; the ability of Chemtrade to obtain
financing on acceptable terms; and the performance of the global
economy as expected.
Actual events and results can be substantially different from
what is expected or implied by the forward-looking information as a
result of risks, uncertainties and other factors, including without
limitation, the factors detailed under the "Risk Factors" section
of the Fund's latest Annual Information Form and the "Risks and
Uncertainties" sections of the Fund's most recent Management's
Discussion and Analysis. These risks and uncertainties include, but
are not limited to: regulatory changes; economic, geopolitical and
other conditions affecting commercial activity; and risks related
to the continued adverse impacts of the COVID-19 pandemic.
All forward-looking information in this release speaks as of the
date of this press release. Except as required by law, the Fund
does not undertake to update or revise any forward-looking
statements, whether as a result of new information, future events
or for any other reason. The forward-looking statements contained
herein are expressly qualified in their entirety by this cautionary
statement.
Further information can be found in the disclosure documents
filed by the Fund with the securities regulatory authorities,
available at www.sedar.com.
SOURCE Chemtrade Logistics Income Fund